Systemic Diseases
Aldeyra’s broad product candidate pipeline applies to many diseases that affect diverse aspects of the body. Thus, we are developing product candidates that can be administered orally or by injection to treat disease systemically. Aldeyra is currently developing potential therapies for the treatment of four immune-mediated systemic diseases:
Ovarian Cancer
Generally diagnosed after significant tumor progression, over 225,000 women have ovarian cancer where a five-year survival is less than 50%.